Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Gigacloud Technology Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Gigacloud Technology Inc trades at $56.35 (market cap $2.00B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2.4× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Gigacloud Technology Inc for 21 Days on average.
| DFTX | GCT | |
|---|---|---|
Market Cap | $4.71B | $2.00B |
Volume | 1,966,636 | 1,000,927 |
Sector | Health | Technology |
52-Week High | $48.45 | $56.42 |
52-Week Low | $10.68 | $25.46 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $3.67B | $2.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GCT trades at $55.96, up 2.19% today, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $1.16, beating estimates of $0.90, continuing a trend of earnings beats. Revenue grew to $1.29 billion in 2025, with net income of $137.37 million and a healthy net margin of 10.65%. The stock is supported by positive cash flow from operations of $190.66 million in 2025.
The outlook for GCT is positive, driven by consistent earnings outperformance and robust profitability metrics like a 32.34% ROE. Risks include potential overbought conditions with an RSI of 72.38 and insider selling activity. Analyst consensus is bullish with a $32.50 price target, though the current price exceeds this, suggesting cautious optimism amid growth execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
